Rocco T., Fang J.Pharmacotherapy of congestive heart failure. In: Brunton L, Lazo J, Parker K, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw Hill; 2006:886-889.
2.
Ratnapalan S. , Griffiths K., Costei AM, et al. Digoxincarvedilol interactions in children. J Pediatr.2003;142: 572-574.
3.
Park M.Congestive heart failure. In: Park MK, ed. Pediatric Cardiology for Practitioners . 4th ed. St Louis, MO: Mosby; 2002:405-406.
4.
Dasgupta A.Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin. Am J Clin Pathol.2002;118:132-140.
5.
Kelly R., Smith T.Recognition and management of digitalis toxicity. Am J Cardiol.1992;69:108G-118G.
6.
Schreiber D., Robertson S.Digitalis toxicity. Available at: http://www.emedicine.com/emerg/topic137.htm. Accessed Nov 16, 2006.
7.
Talner N.Heart failure. In: Moss AJ, Adams FH, Emmanouilides GC , eds. Moss and Adams: Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult. 5th ed. Philadelphia, PA: Williams & Wilkins; 1995:1763-1765.
8.
Woolf A., Wenger T., Smith T., et al. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children. N Engl J Med.1992 ;326:1739-1744.
9.
Davey M.Calcium for hyperkalaemia in digoxin toxicity. Emerg Med J . 2002; 19: 183.
